EQIN yields 1.98% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, EQIN + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EQIN + MRK for your $10,000?
EQIN seeks total return by holding an income-producing equity portfolio of primarily large- and mid-cap US companies. To be eligible for inclusion, each company must have a low ESG Materiality Rating and a forward annualized dividend yield of at least 1%. Eligible companies are scored on a sector-relative basis, focusing on forward dividend yield, dividend growth, and cash-based dividend coverage ratio factors. The fund selects the 100 highest-scoring securities and weights the resulting portfolio on a market cap basis. Although the fund is actively managed, it applies investing rules at least quarterly. Before Oct. 14, 2022, the fund traded as Columbia Sustainable U.S. Equity Income ETF and tracked the Beta Advantage U.S. ESG Equity Income Index. Prior to June 3, 2024, the fund was named Columbia U.S. ESG Equity Income ETF, traded under the ticker ESGS, and tracked the Beta Advantage U.S. ESG Equity Income Index.
Full EQIN Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.